Clinical trial
Methotrexate in Ankylosing Spondylitis (MTX in AS)
NCT00243750 · Charite University, Berlin, Germany, Other · Unknown status
Key facts
| NCT number | NCT00243750 |
|---|---|
| Title | Methotrexate in Ankylosing Spondylitis (MTX in AS) |
| Official title | Open Study for the Evaluation of the Efficacy of Methotrexate 20mg Given Subcutaneously in Patients With Active Ankylosing Spondylitis |
| Lead sponsor | Charite University, Berlin, Germany, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ankylosing Spondylitis |
| Intervention type | Drug |
| Interventions | Methotrexate |
| Enrollment | 20 |
| Start date | Sep 1, 2003 |
| Completion | Nov 1, 2005 |
| First posted | Oct 25, 2005 |
| Last update posted | Dec 9, 2005 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: